Related Experiment Videos
The EWS/ATF1 fusion protein contains a dispersed activation domain that functions directly
1Department of Biology, Hong Kong University of Science & Technology, Kowloon, PRC.
Abstract:
Naturally occurring chromosomal fusion of the Ewings Sarcoma Oncogene (EWS) to distinct cellular transcription factors, produces aberrant transcriptional activators that function as dominant oncogenes. In Malignant Melanoma of Soft Parts the N-terminal region of EWS is fused to C-terminal region of the cAMP-inducible transcription factor ATF1. The EWS/ATF1 fusion protein binds to ATF sites present in cAMP-responsive promoters via the ATF1 bZIP domain and activates transcription constitutively in a manner that is dependent on an activation domain (EAD) present in EWS. To further define the requirements for trans-activation we have performed mutational analysis of EWS/ATF1 in mammalian cells and report several new findings. First, trans-activation by EWS/ATF1 does not require dimerisation with other ATF family members present in mammalian cells. Second, in contrast to the earlier suggestion of an allosteric role, the EAD can act directly. Third, determinants of trans-activation are dispersed throughout the EAD and cooperate synergistically to produce potent trans-activation. We also report that the region of EWS containing the EAD can activate transcription in Yeast. This latter finding might enable a genetic approach to understanding the mechanism of transcriptional activation by EWS and development of high-throughput screens for EWS inhibitors.
Insights
The Ewings Sarcoma Oncogene (EWS)/ATF1 fusion protein drives cancer by constitutively activating transcription. Mutational analysis reveals its activation domain directly drives transcription, independent of other factors.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Chromosomal fusions involving the Ewings Sarcoma Oncogene (EWS) create dominant oncogenes.
- Malignant Melanoma of Soft Parts involves an EWS/ATF1 fusion protein that constitutively activates transcription.
Purpose of the Study:
- To elucidate the molecular mechanisms of EWS/ATF1-mediated trans-activation.
- To define the role and requirements of the EWS-derived activation domain (EAD).
Main Methods:
- Mutational analysis of the EWS/ATF1 fusion protein in mammalian cells.
- Investigating transcriptional activation in yeast models.
Main Results:
- EWS/ATF1 trans-activation does not require dimerization with other ATF family members.
- The EWS-derived activation domain (EAD) acts directly, not allosterically.
- Key determinants for trans-activation are dispersed within the EAD and act synergistically.
- The EWS EAD can activate transcription in yeast.
Conclusions:
- The EWS/ATF1 fusion protein's oncogenic activity is driven by direct, synergistic action of its EAD.
- Yeast-based assays offer a potential genetic approach to study EWS transcriptional activation and identify inhibitors.